HOME >> MEDICINE >> NEWS
Bone Marrow With Heart And Lung Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh

Results of clinical study presented at international transplant meeting

SAN FRANCISCO, April 24 -- Organ rejection occurs less often and is less severe in heart and lung transplant patients who receive infusions of bone marrow from the same donor, researchers from the University of Pittsburgh Medical Center (UPMC) reported today at the International Society for Heart and Lung Transplantation Annual Meeting.

"These results are particularly significant because hearts and lungs are usually more prone to rejection than other organs. Their cell composition contains fewer donor immune system cells that serve as natural defenses against an attack by the recipient's immune system; donor bone marrow seems to enhance the immune capabilities and reduce the likelihood of rejection," explained Kenneth McCurry, M.D., assistant professor of surgery, division of cardiothoracic surgery, at UPMC.

Controlling rejection is the key to successful organ transplantation. For the most part, surgeons rely on drugs that suppress the patient's immune response as their main line of defense against an immune system attack. But despite newer and better drugs, organ rejection can still occur, even years after transplantation.

The study included 31 heart and 26 lung transplant patients who received donor bone marrow within 72 hours of their transplant operations. The results were compared to 24 heart and 26 lung recipients who received organ transplants without bone marrow.

By giving donor bone marrow, the researchers' aim was to enhance the cellular environment called chimerism, defined as the coexistence of recipient and donor immune cells. Having already proved that chimerism is present in long-term survivors of kidney and liver organ transplants, some of whom have been weaned from a life-long regimen of immunosupressant drugs, researchers wanted to promote, even hasten this biological process with bone marrow.

In heart transplant patient
'"/>

Contact: Lisa Rossi
rossiL@msx.upmc.edu
412-624-2607
University of Pittsburgh Medical Center
24-Apr-1999


Page: 1 2 3

Related medicine news :

1. Marrow injection gets damaged hearts moving
2. Less Toxic Bone Marrow Transplant Technique May Have More Powerful Anti-Cancer Effect
3. Organ Transplants Helped By Donor Bone Marrow, University Of Pittsburgh Researchers Report At National Transplant Meetings
4. Bone Marrow With Organ Transplants Reduces Rejection Of Transplanted Organs, Reports University Of Pittsburgh
5. Duke Researchers Identify New Pulmonary Syndrome Associated With Bone Marrow Transplantation For Breast Cancer
6. The European Society of Cardiology launches Women at Heart
7. Heart surgeons publish death rates
8. Heart attack treatment gap may be closing for women
9. The Larry King Cardiac Foundation presents The Changing Face of Heart Disease on Feb. 2
10. Brenner Childrens Hospital named to NIH Pediatric Heart Network
11. Heart patients treated by non-cardiologists less likely to receive medications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
(Date:9/18/2017)... , Sept. 18, 2017  PMD Healthcare of ... Pharmacy of Kalamazoo, Mich. , have ... service that expedites and streamlines patient and provider access ... 2.0, and wellness management services.  ... used to measure lung function for a variety of ...
Breaking Medicine Technology:
Cached News: